Cargando…
Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophrenia
BACKGROUND: One-third of patients with schizophrenia are treatment-resistant to non-clozapine antipsychotics (TRS), while the rest respond (NTRS). Examining whether TRS and NTRS represent different pathophysiologies is an important step toward precision medicine. METHODS: Focusing on cortical thickn...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527893/ https://www.ncbi.nlm.nih.gov/pubmed/34638035 http://dx.doi.org/10.1016/j.nicl.2021.102852 |
_version_ | 1784586159382331392 |
---|---|
author | Itahashi, Takashi Noda, Yoshihiro Iwata, Yusuke Tarumi, Ryosuke Tsugawa, Sakiko Plitman, Eric Honda, Shiori Caravaggio, Fernando Kim, Julia Matsushita, Karin Gerretsen, Philip Uchida, Hiroyuki Remington, Gary Mimura, Masaru Aoki, Yuta Y. Graff-Guerrero, Ariel Nakajima, Shinichiro |
author_facet | Itahashi, Takashi Noda, Yoshihiro Iwata, Yusuke Tarumi, Ryosuke Tsugawa, Sakiko Plitman, Eric Honda, Shiori Caravaggio, Fernando Kim, Julia Matsushita, Karin Gerretsen, Philip Uchida, Hiroyuki Remington, Gary Mimura, Masaru Aoki, Yuta Y. Graff-Guerrero, Ariel Nakajima, Shinichiro |
author_sort | Itahashi, Takashi |
collection | PubMed |
description | BACKGROUND: One-third of patients with schizophrenia are treatment-resistant to non-clozapine antipsychotics (TRS), while the rest respond (NTRS). Examining whether TRS and NTRS represent different pathophysiologies is an important step toward precision medicine. METHODS: Focusing on cortical thickness (CT), we analyzed international multi-site cross-sectional datasets of magnetic resonance imaging comprising 110 patients with schizophrenia (NTRS = 46, TRS = 64) and 52 healthy controls (HCs). We utilized a logistic regression with L1-norm regularization to find brain regions related to either NTRS or TRS. We conducted nested 10-fold cross-validation and computed the accuracy and area under the curve (AUC). Then, we applied the NTRS classifier to patients with TRS, and vice versa. RESULTS: Patients with NTRS and TRS were classified from HCs with 65% and 78% accuracies and with the AUC of 0.69 and 0.85 (p = 0.014 and < 0.001, corrected), respectively. The left planum temporale (PT) and left anterior insula/inferior frontal gyrus (IFG) contributed to both NTRS and TRS classifiers. The left supramarginal gyrus only contributed to NTRS and right superior temporal sulcus and right lateral orbitofrontal cortex only to the TRS. The NTRS classifiers successfully distinguished those with TRS from HCs with the AUC of 0.78 (p < 0.001), while the TRS classifiers classified those with NTRS from HCs with the AUC of 0.69 (p = 0.015). CONCLUSION: Both NTRS and TRS could be distinguished from HCs on the basis of CT. The CT pathological basis of NTRS and TRS has commonalities, and TRS presents unique CT features. |
format | Online Article Text |
id | pubmed-8527893 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-85278932021-10-27 Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophrenia Itahashi, Takashi Noda, Yoshihiro Iwata, Yusuke Tarumi, Ryosuke Tsugawa, Sakiko Plitman, Eric Honda, Shiori Caravaggio, Fernando Kim, Julia Matsushita, Karin Gerretsen, Philip Uchida, Hiroyuki Remington, Gary Mimura, Masaru Aoki, Yuta Y. Graff-Guerrero, Ariel Nakajima, Shinichiro Neuroimage Clin Regular Article BACKGROUND: One-third of patients with schizophrenia are treatment-resistant to non-clozapine antipsychotics (TRS), while the rest respond (NTRS). Examining whether TRS and NTRS represent different pathophysiologies is an important step toward precision medicine. METHODS: Focusing on cortical thickness (CT), we analyzed international multi-site cross-sectional datasets of magnetic resonance imaging comprising 110 patients with schizophrenia (NTRS = 46, TRS = 64) and 52 healthy controls (HCs). We utilized a logistic regression with L1-norm regularization to find brain regions related to either NTRS or TRS. We conducted nested 10-fold cross-validation and computed the accuracy and area under the curve (AUC). Then, we applied the NTRS classifier to patients with TRS, and vice versa. RESULTS: Patients with NTRS and TRS were classified from HCs with 65% and 78% accuracies and with the AUC of 0.69 and 0.85 (p = 0.014 and < 0.001, corrected), respectively. The left planum temporale (PT) and left anterior insula/inferior frontal gyrus (IFG) contributed to both NTRS and TRS classifiers. The left supramarginal gyrus only contributed to NTRS and right superior temporal sulcus and right lateral orbitofrontal cortex only to the TRS. The NTRS classifiers successfully distinguished those with TRS from HCs with the AUC of 0.78 (p < 0.001), while the TRS classifiers classified those with NTRS from HCs with the AUC of 0.69 (p = 0.015). CONCLUSION: Both NTRS and TRS could be distinguished from HCs on the basis of CT. The CT pathological basis of NTRS and TRS has commonalities, and TRS presents unique CT features. Elsevier 2021-10-07 /pmc/articles/PMC8527893/ /pubmed/34638035 http://dx.doi.org/10.1016/j.nicl.2021.102852 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Regular Article Itahashi, Takashi Noda, Yoshihiro Iwata, Yusuke Tarumi, Ryosuke Tsugawa, Sakiko Plitman, Eric Honda, Shiori Caravaggio, Fernando Kim, Julia Matsushita, Karin Gerretsen, Philip Uchida, Hiroyuki Remington, Gary Mimura, Masaru Aoki, Yuta Y. Graff-Guerrero, Ariel Nakajima, Shinichiro Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophrenia |
title | Dimensional distribution of cortical abnormality across antipsychotics
treatment-resistant and responsive schizophrenia |
title_full | Dimensional distribution of cortical abnormality across antipsychotics
treatment-resistant and responsive schizophrenia |
title_fullStr | Dimensional distribution of cortical abnormality across antipsychotics
treatment-resistant and responsive schizophrenia |
title_full_unstemmed | Dimensional distribution of cortical abnormality across antipsychotics
treatment-resistant and responsive schizophrenia |
title_short | Dimensional distribution of cortical abnormality across antipsychotics
treatment-resistant and responsive schizophrenia |
title_sort | dimensional distribution of cortical abnormality across antipsychotics
treatment-resistant and responsive schizophrenia |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527893/ https://www.ncbi.nlm.nih.gov/pubmed/34638035 http://dx.doi.org/10.1016/j.nicl.2021.102852 |
work_keys_str_mv | AT itahashitakashi dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia AT nodayoshihiro dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia AT iwatayusuke dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia AT tarumiryosuke dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia AT tsugawasakiko dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia AT plitmaneric dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia AT hondashiori dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia AT caravaggiofernando dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia AT kimjulia dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia AT matsushitakarin dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia AT gerretsenphilip dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia AT uchidahiroyuki dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia AT remingtongary dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia AT mimuramasaru dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia AT aokiyutay dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia AT graffguerreroariel dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia AT nakajimashinichiro dimensionaldistributionofcorticalabnormalityacrossantipsychoticstreatmentresistantandresponsiveschizophrenia |